Skip to main content
Category

News Archive

childrens-national-health-gwu-logo

Children’s National, in partnership with The George Washington University, receives second Clinical and Translational Science Award – Children’s National Health System

By News Archive

childrens-national-health-gwu-logo

The National Center for Advancing Translational Sciences at the National Institutes of Health has awarded Children’s National Health System, in partnership with The George Washington University (GW), another prestigious Clinical and Translational Science Award. The grant, made available to facilities across the nation through a competitive process, underwrites the existing Clinical and Translational Science Institute at Children’s National (CTSI-CN) and provides funding that is essential to continue the collaborative pediatric-focused translational research occurring at Children’s and at GW. 

Read More
ncet2-logo

UNIVERSITY STARTUP DEVELOPMENT WEBINAR SERIES – NCET2

By News Archive

ncet2-logo

Experienced Startup Development Officers Help Universities, Faculty, Researchers, Students and Entrepreneurs Create, Develop and Fund University Startups and IP

Join this webinar to learn more about: How to Attract Venture Capital Wednesday, September 6, 1:00 pm ET/10:00 am PT

WHO SHOULD ATTEND: Researchers, Students, Faculty, Entrepreneurs, Startups, Vice Presidents of Research, University Tech Transfer Offices, Open Innovation Officers, Chief Innovation Officers, Angel Groups, VCs, University Venture Funds, University Angel Groups

Read More
Nanochon-gw-image

Nanochon LLC Receives Small Business Grant

By News Archive

Nanochon-gw-image

In July 2017, Nanochon LLC and CEO Ben Holmes were awarded a Phase I SBIR grant from the National Science Foundation. The grant will fund the development of an implantable medical device for cartilage repair in the knee, based on 3D printing technology. Nanochon LLC was founded by Ben Holmes and Nathan Castro and is based on their work in Grace Zhang’s Tissue Engineering Lab.

Read More
fda-logo

What Can Scott Gottlieb Do To Advance The FDA Clinical Trials

By News Archive

fda-logo

On May 11, Scott Gottlieb, M.D., officially became the 23rd commissioner of the U.S. Food and Drug Administration (FDA). Dr. Gottlieb has previous FDA experience, having served as deputy commissioner for medical and scientific affairs, among other positions, during the George W. Bush administration. More recently, he was a venture partner at the world’s largest venture capitalist firm, New Enterprise Associates (NEA), sitting on the boards of several pharmaceutical companies, including GSK, Daiichi Sankyo, and Vertex. He was also a clinical assistant professor and practiced medicine at the New York University (NYU) School of Medicine, and is a cancer survivor (Hodgkin’s lymphoma).

Read More
sharevault-logo

From Founding to Exit: A Life Sciences, Business Founder Perspective – ShareVault

By News Archive

sharevault-logo

September 28, 2017 11a PT/ 2p ET

Join us for a web panel discussion on how to successfully move a life science organization from founding to exit. During this discussion, founders will provide guidance on how executive teams can partner business and science together to overcome the stumbling blocks along the way and achieve results.  Learn what is real and what is myth!

Read More
BHCR logo 500

The BioHealth Capital Region Rises to #5 in GEN’s Annual Rankings of BioPharma Clusters

By News Archive

BHCR logo 500

This summer in the Genetic Engineering & Biotechnology News Annual Rankings of the “Top 10 U.S. Biopharma Clusters”, the BioHealth Capital Region (BHCR) moved up to #5. NIH funding, Venture Capital funding, Patents, Lab Space, and Jobs all are factored into the BHCR’s move into the Top-5.

“Area biopharma leaders have committed to growing their “BioHealth Capital Region” cluster into one of the nation’s top three by 2023, building on anchors ranging from the NIH and FDA, to the nation’s top academic recipient of research grant funding, the Johns Hopkins University. Hopkins accounts for 64.5% of the region’s NIH funding (556 awards totaling $271.4 million), placing fourth with 880 awards totaling nearly $420.7 million. The region is close to meeting its goal in patents (fourth with 4,108), but further back in employment (eighth with 39,145 jobs, according to JLL) and lab space (sixth with 9.5 million square feet).

Vaccine developers continue to grow: In May, Gaithersburg-based Emergent BioSciences opened an $80 million expanded medical countermeasures plant in East Baltimore, while GlaxoSmithKline announced a $139 million capacity expansion at its API plant in Rockville, MD, due to growing demand for its lupus erythematosus treatment Benlysta® (belimumab). The region finished sixth in VC funding last year ($146 million), but climbed to fourth during Q1 (seven awards totaling $71 million). Courting the industry eagerly are both Virginia Gov. Terry McAuliffe (D) and Maryland Gov. Larry Hogan (R), a non-Hodgkin’s lymphoma survivor who calls the cluster-building effort a personal mission.”

Click here to read the entire article via Gen

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.